Second, post-marketing data reveal that real-world adherence and persistence are lower than in clinical trials, often due to gastrointestinal side effects, treatment fatigue, or cost-related barriers (143145)
1 The compounded semaglutide products provided by Noom are not reviewed by FDA for safety, efficacy, or quality
And make sure you are storing your medication properly , as degraded peptides can cause more injection site irritation than fresh ones
Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage
Here is the mechanism: insulin is not the only way to move GLUT4 transporters to the cell surface